Advanced Biomed Inc.

8-K Terminated a material agreement Jul 17, 2026 8-K Shareholder vote results Jul 1, 2026 8-K Entered a material agreement Jun 30, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Completed an acquisition or disposition; Unregistered sale of equity; Director or officer change May 1, 2026 8-K Entered a material agreement Apr 14, 2026 8-K Entered a material agreement Apr 3, 2026 8-K Director or officer change Mar 30, 2026 8-K Other events Mar 16, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Other events Feb 26, 2026 10-Q Quarter ended 2025-12-31 Feb 13, 2026 8-K/A Unregistered sale of equity Feb 10, 2026 8-K Entered a material agreement; Unregistered sale of equity Feb 2, 2026 8-K Entered a material agreement Jan 27, 2026 8-K Delisting notice or listing-rule failure Jan 21, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Regulation FD disclosure Dec 30, 2025 10-Q Quarter ended 2025-09-30 Nov 19, 2025 10-K Fiscal year ended 2025-06-30 Oct 8, 2025 8-K Regulation FD disclosure Sep 19, 2025 8-K Delisting notice or listing-rule failure Jul 24, 2025 8-K Entered a material agreement Jun 6, 2025 8-K Director or officer change May 28, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 10-Q Quarter ended 2024-12-31 Apr 15, 2025 8-K Entered a material agreement; Regulation FD disclosure Mar 10, 2025 RW WITHDRAWAL REQUEST Jul 20, 2026 DEF 14A DEFINITIVE PROXY STATEMENT Jun 4, 2026 DEF 14C DEFINITIVE INFORMATION STATEMENT Jan 23, 2026 PRE 14C PRELIMINARY INFORMATION STATEMENT Jan 12, 2026 NT 10-Q NOTIFICATION OF LATE FILING Nov 14, 2025 NT 10-K NOTIFICATION OF LATE FILING Sep 30, 2025 S-1 REGISTRATION STATEMENT Jul 23, 2025 424B3 FORM 424B3 Mar 6, 2025 424B4 FORM 424B4 Mar 6, 2025 424B4 FORM 424B4 Mar 6, 2025 CERT Mar 6, 2025 8-A12B FORM 8A-12(B) Mar 5, 2025 FWP FORM FWP Feb 18, 2025 SEC STAFF LETTER Feb 13, 2025 EFFECT Feb 11, 2025